NMPA accepts clinical trial application for monkeypox vaccine

chinadaily.com.cn | Updated: 2023-07-14 19:44

Share - WeChat

The National Medical Products Administration (NMPA) has, on Thursday, officially accepted the clinical trial application for the replication-deficient monkeypox vaccine developed by China National Pharmaceutical Group Corporation (Sinopharm) Beijing Institute of Biological Products.

Photo

Shanghai Museum to spotlight ancient Chinese civilization of Hongshan Culture

Disney, Shanghai studio to jointly release animated shorts featuring Zootopia characters

International students explore Shenyang's heritage

Mood wall lets commuters tap feelings in Changsha

Youth exchanges bridge US-China understanding in Hainan

Long March rockets debut at Paris show

Latest

State Council News

China's economy in May, 2025

Exclusive

Humanoid robot for all: Even high schoolers can join in

Xiaomi revolutionizes production with 76-sec car roll out

Measures implemented to assist students sitting gaokao

Newsmaker

Chinese meteorologist wins WMO's highest honor

On a mission to restore old Hakka houses

Ten photos you don't wanna miss

Ten photos from across China: June 13 - 19

Special Coverage

The Real Xinjiang through a Thousand Voices

2025 NPC & CPPCC National Committee annual sessions

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.

Registration Number: 130349